Comparative Analysis of Molecular Functions and Biological Role of Proteins from Cell-Free DNA-Protein Complexes Circulating in Plasma of Healthy Females and Breast Cancer Patients

被引:3
作者
Tutanov, Oleg [1 ]
Shefer, Aleksei [1 ]
Tsentalovich, Yuri [2 ]
Tamkovich, Svetlana [1 ]
机构
[1] Novosibirsk State Univ, V Zelman Inst Med & Psychol, Novosibirsk 630090, Russia
[2] Russian Acad Sci, Int Tomog Ctr, Siberian Branch, Novosibirsk 630090, Russia
基金
俄罗斯科学基金会;
关键词
histones; circulating DNA; nucleoprotein complexes; plasma; MALDI-TOF mass spectrometry; breast cancer; RELEASE; TUMOR; ACTIVATION; BINDING; BLOOD; HMGB1;
D O I
10.3390/ijms24087279
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cell-free DNA (cfDNA) circulates in the bloodstream packed in membrane-coated structures (such as apoptotic bodies) or bound to proteins. To identify proteins involved in the formation of deoxyribonucleoprotein complexes circulating in the blood, native complexes were isolated using affinity chromatography with immobilized polyclonal anti-histone antibodies from plasma of healthy females (HFs) and breast cancer patients (BCPs). It was found that the nucleoprotein complexes (NPCs) from HF plasma samples contained shorter DNA fragments (similar to 180 bp) than BCP NPCs. However, the share of DNA in the NPCs from cfDNA in blood plasma in HFs and BCPs did not differ significantly, as well as the share of NPC protein from blood plasma total protein. Proteins were separated by SDS-PAGE and identified by MALDI-TOF mass spectrometry. Bioinformatic analysis showed that in the presence of a malignant tumor, the proportion of proteins involved in ion channels, protein binding, transport, and signal transduction increased in the composition of blood-circulating NPCs. Moreover, 58 (35%) proteins are differentially expressed in a number of malignant neoplasms in the NPCs of BCPs. Identified NPC proteins from BCP blood can be recommended for further testing as breast cancer diagnostic/prognostic biomarkers or as being useful in developing gene-targeted therapy approaches.
引用
收藏
页数:20
相关论文
共 49 条
[1]   Kinetic analysis, size profiling, and bioenergetic association of DNA released by selected cell lines in vitro [J].
Aucamp, Janine ;
Bronkhorst, Abel J. ;
Peters, Dimetrie L. ;
Van Dyk, Hayley C. ;
Van der Westhuizen, Francois H. ;
Pretorius, Piet J. .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2017, 74 (14) :2689-2707
[2]   Impact of estrogen receptor α on the tamoxifen response and prognosis in luminal-A-like and luminal-B-like breast cancer [J].
Babyshkina, Nataliya ;
Vtorushin, Sergey ;
Dronova, Tatyana ;
Patalyak, Stanislav ;
Slonimskaya, Elena ;
Kzhyshkowska, Julia ;
Cherdyntseva, Nadejda ;
Choynzonov, Evgeny .
CLINICAL AND EXPERIMENTAL MEDICINE, 2019, 19 (04) :547-556
[3]   Circulating nucleosomes as epigenetic biomarkers in pancreatic cancer [J].
Bauden, Monika ;
Pamart, Dorian ;
Ansari, Daniel ;
Herzog, Marielle ;
Eccleston, Mark ;
Micallef, Jake ;
Andersson, Bodil ;
Andersson, Roland .
CLINICAL EPIGENETICS, 2015, 7
[4]   New Perspectives on the Importance of Cell-Free DNA Biology [J].
Bronkhorst, Abel J. ;
Ungerer, Vida ;
Oberhofer, Angela ;
Gabriel, Sophie ;
Polatoglou, Eleni ;
Randeu, Hannah ;
Uhlig, Carsten ;
Pfister, Heiko ;
Mayer, Zsuzsanna ;
Holdenrieder, Stefan .
DIAGNOSTICS, 2022, 12 (09)
[5]   Concentration of cell-free DNA in different tumor types [J].
Bryzgunova, O. E. ;
Konoshenko, M. Yu ;
Laktionov, P. P. .
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2021, 21 (01) :63-75
[6]   Redistribution of Free- and Cell-Surface-Bound DNA in Blood of Benign and Malignant Prostate Tumor Patients [J].
Bryzgunova, O. E. ;
Tamkovich, S. N. ;
Cherepanova, A. V. ;
Yarmoshchuk, S. V. ;
Permyakova, V. I. ;
Anykeeva, O. Y. ;
Laktionov, P. P. .
ACTA NATURAE, 2015, 7 (02) :115-118
[7]   Proteins involved in binding and cellular uptake of nucleic acids [J].
Chelobanov, B. P. ;
Laktionov, P. P. ;
Vlasov, V. V. .
BIOCHEMISTRY-MOSCOW, 2006, 71 (06) :583-596
[8]   De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017 [J].
Curigliano, G. ;
Burstein, H. J. ;
Winer, E. P. ;
Gnant, M. ;
Dubsky, P. ;
Loibl, S. ;
Colleoni, M. ;
Regan, M. M. ;
Piccart-Gebhart, M. ;
Senn, H. -J. ;
Thurlimann, B. ;
Andre, F. ;
Baselga, J. ;
Bergh, J. ;
Bonnefoi, H. ;
Brucker, S. Y. ;
Cardoso, F. ;
Carey, L. ;
Ciruelos, E. ;
Cuzick, J. ;
Denkert, C. ;
Di Leo, A. ;
Ejlertsen, B. ;
Francis, P. ;
Galimberti, V. ;
Garber, J. ;
Gulluoglu, B. ;
Goodwin, P. ;
Harbeck, N. ;
Hayes, D. F. ;
Huang, C. -S. ;
Huober, J. ;
Khaled, H. ;
Jassem, J. ;
Jiang, Z. ;
Karlsson, P. ;
Morrow, M. ;
Orecchia, R. ;
Osborne, K. C. ;
Pagani, O. ;
Partridge, A. H. ;
Pritchard, K. ;
Ro, J. ;
Rutgers, E. J. T. ;
Sedlmayer, F. ;
Semiglazov, V. ;
Shao, Z. ;
Smith, I. ;
Toi, M. ;
Tutt, A. .
ANNALS OF ONCOLOGY, 2017, 28 (08) :1700-1712
[9]   Frequent copresence of methylated DNA and fragmented nucleosomal DNA in plasma of lymphoma patients [J].
Deligezer, U ;
Yaman, F ;
Erten, N ;
Dalay, N .
CLINICA CHIMICA ACTA, 2003, 335 (1-2) :89-94
[10]   Clinical utility of liquid biopsy in breast cancer: A systematic review [J].
Duque, Galo ;
Manterola, Carlos ;
Otzen, Tamara ;
Arias, Cristina ;
Galindo, Bryan ;
Mora, Miriann ;
Guerrero, Enmanuel ;
Garcia, Nayeli .
CLINICAL GENETICS, 2022, 101 (03) :285-295